ClinicalTrials.Veeva

Menu

Chromosome 9 P Minus Syndrome

The Washington University logo

The Washington University

Status

Enrolling

Conditions

9P Monosomy
Chromosome 9P Deletion Syndrome
Alfi Syndrome
9p Minus Syndrome
9P Partial Monosomy Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT04586400
201706062

Details and patient eligibility

About

Patients with deletion of chromosome 9 P are rare (~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic background in affected patients (whole genome sequencing) and correlate the genes in the deleted portion of chromosome 9 P with specific phenotypic characteristics of each patient. Enrolled participants will be asked to complete a detailed questionnaire, complete a medical release form, and provide a biospecimen sample.

Enrollment

200 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Having 9P minus syndrome/ deletions on the 9th chromosome
  • Parents and siblings of affected individuals may also be included to determine contribution of genetic background to phenotypic characteristics

Exclusion criteria

  • No exclusion criteria for either affected individuals or their parents or siblings.

Trial contacts and locations

1

Loading...

Central trial contact

Sophia Couteranis; F. S. Cole, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems